Clinical outcomes and patient satisfaction after Visian Implantable Collamer Lens removal and phacoemulsification with intraocular lens implantation in eyes with induced cataract.
To assess the clinical outcomes and patient satisfaction after simultaneous Implantable Collamer Lens (ICL) removal and phacoemulsification with intraocular lens (IOL) implantation in ICL-implanted eyes with developing cataracts. We retrospectively reviewed the clinical charts of 10 eyes of eight patients who developed significant cataract after ICL implantation. Patient age was 47.2+/-5.9 (mean+/-SD) years (range, 37-57 years). We determined visual acuity (log MAR), manifest refraction, endothelial cell density, and subjective satisfaction with visual outcomes measured using a visual analogue scale, that ranged from 0 (very dissatisfied) to 10 (very satisfied), before and 3 months after cataract surgery. Log MAR best spectacle-corrected visual acuity was significantly improved from 0.19+/-0.30 preoperatively to -0.06+/-0.07 postoperatively (P=0.007, Wilcoxon signed-rank test). Eight (80%) and nine (90%) of the 10 eyes were within 0.5 D (diopter) and 1.0 D of the targeted correction, respectively. The endothelial cell density was 2584.9+/-266.2 cells/mm(2) preoperatively, and 2340.1+/-269.7 cells/mm(2) postoperatively. The overall satisfaction with visual outcomes was scored 1.8+/-1.1 (range: 0-3) preoperatively, and 7.9+/-1.4 (range: 6-10) postoperatively. No vision-threatening complications were seen throughout the follow-up period. Simultaneous ICL removal and phacoemulsification with IOL implantation was safe and effective with predictable refractive results, and thus yielded a high level of patient satisfaction with ICL-induced cataract treatment.